James Patrick McGraw

Associate

Emailjames.mcgraw@us.dlapiper.com

About

Areas of FocusLife Sciences Corporate Technology Life Sciences Transactions Technology and Commercial Transactions Healthcare Mergers and Acquisitions Life Sciences Licensing and Strategic Transactions

Bar admissionsDistrict of ColumbiaPennsylvania

EXPERIENCE

Represented a U.S. publicly traded company in a multinational license agreement worth over $1 billion in upfront, milestone and royalty payments with a Chinese pharmaceutical company.
Represented a publicly traded multinational research company based in India in a research collaboration agreement worth over $500 million with a healthcare investment company.
Represented an early-stage U.S. pharmaceutical company in a license agreement worth over $300 million in upfront and milestone and royalty payments with a publicly traded pharmaceutical company.
Represented an academic institution in a funding and research agreement worth over $250 million in laboratory funding and sponsored research with an investor-backed drug discovery enterprise.
Represented U.S. publicly traded company in a license agreement worth over $240 million in upfront, milestone and royalty payments with a Taiwan pharmaceutical company.
Represented an international pharmaceutical company in its re-negotiation of a license and collaboration agreement worth over $100 million with a U.S. pharmaceutical company.
Represented an early-stage U.S. pharmaceutical company in a license agreement worth over $75 million in upfront, milestone and royalty payments with an international pharmaceutical company.
Represented a U.S. publicly traded company in a license agreement with an international NGO to allow suppliers to manufacture a generic version of its COVID-19 drug treatment for low-income countries.
Represented a an academic university in the spin-off of one of its premier laboratories into a for-profit biotechnology company and a contract development manufacturing organization.
Represented a publicly traded biotechnology company in a $250 million revenue interest purchase agreement with a multinational life sciences investment firm.
Represented a pharmaceutical company in a $150 million funding transaction with a global private equity firm.
Represented a U.S. publicly traded company in global manufacturing services agreement for a dedicated manufacturing facility with a leading international contract manufacturing organization.
Represented various pharmaceutical and biotechnology companies in the establishment of their clinical study operations, including negotiation of clinical trial agreements globally and key contract research agreements.
Represented various pharmaceutical and biotechnology companies in the establishment of their clinical and commercial supply chains.

Education

J.D., Temple University School of Law
Temple Law Review
cum laude

B.A., Political Science and English, Saint Joseph's University
Phi Beta Kappa
cum laude

Prior Experience

Before and during law school, James worked in the in-house legal department of a Fortune 100 company, where he negotiated contracts, reviewed sales and marketing materials and counselled clients on a wide range of legal and business issues.

Memberships And Affiliations